Pharmacy-Based Administration of Long-Acting Injectables: A Sharp Idea

Upon successful completion of this module, pharmacists should be able to:
1. Describe the signs, symptoms, and diagnostic criteria for schizophrenia and bipolar disorder.
2. List the benefits and challenges associated with the use of long-acting injectable (LAI) antipsychotics.
3. Compare the FDA-approved LAI antipsychotics, including preparation and administration.
4. Discuss the role of the pharmacist in the administration of LAI antipsychotics in the pharmacy setting.
5. Formulate a strategy to transition a case-based patient from an oral antipsychotic to a LAI antipsychotic.

Upon successful completion of this module, pharmacists should be able to:
1. Review the various types of injections that may be delivered in pharmacy practice.
2. Identify techniques and recommended practices for delivering injectable medications.
3. Assess the appropriate injection method based on patient factors, medication characteristics, and safety considerations.

Upon successful completion of this module, pharmacists should be able to:
1. Discuss the opportunities and challenges of developing a LAI service.
2. Describe the key components and procedures necessary for implementing a LAI administration service.
3. Develop a policy, procedure, and plan for providing LAI administration services.
4. Recognize options to expand LAI administration through community partnerships.

Upon successful completion of this module, pharmacists should be able to:
1. Identify the considerations for administering long-acting injectables (LAIs).
2. Describe common FDA-approved non-antipsychotic LAIs administered at the pharmacy.
3. Discuss monitoring and follow-up plan recommendations for each injection.
4. Develop a treatment plan to transition a case-based patient from an oral medication to an LAI non- antipsychotic.